Ausdal Financial Partners’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$167K Buy
12,338
+42
+0.3% +$502 0.01% 1006
2026
Q1
$73.7K Sell
12,296
-3,060
-20% -$23K ﹤0.01% 973
2025
Q4
$110K Sell
15,356
-1,707
-10% -$13.5K 0.01% 922
2025
Q3
$182K Buy
17,063
+938
+6% +$9.21K 0.01% 902
2025
Q2
$156K Buy
16,125
+450
+3% +$4.64K 0.01% 670
2025
Q1
$233K Buy
+15,675
New +$241K 0.02% 568
2024
Q3
Sell
-9,745
Closed -$202K 541
2024
Q2
$202K Buy
+9,745
New +$194K 0.02% 471

Other funds holding OGN

Ausdal Financial Partners's OGN Position: Q2 2026 in Review

Ausdal Financial Partners increased its Organon & Co (OGN) stake by 0.34% in Q2 2026, buying an estimated $502 and bringing the position to 12,338 shares worth $167K. The position accounts for 0.01% of the portfolio, ranked #1006.

Ausdal Financial Partners first reported a position in OGN in Q2 2024 and has held it in 7 quarters since. The position peaked at $233K in Q1 2025. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Ausdal Financial Partners held 12,338 shares of Organon & Co worth $167K as of Q2 2026.
  • Ausdal Financial Partners bought 42 Organon & Co shares in Q2 2026, an estimated $502.
  • Organon & Co made up 0.01% of Ausdal Financial Partners's portfolio in Q2 2026, its #1006 holding.
  • Ausdal Financial Partners first reported a position in Organon & Co in Q2 2024 and has held it in 7 quarters since.
  • Ausdal Financial Partners's Organon & Co position peaked at $233K in Q1 2025.
  • 631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Ausdal Financial Partners's 13F filing for Q2 2026, filed 14 Aug 2026.